ABSTRACT Proteins in the ALA-D (8-aminolaevulinic acid dehydratase) fraction from gel filtration of erythrocyte supematant (ES) have the highest affinity for lead among erythrocyte constituents in vivo and in vitro. It takes 20-40 hours for erythrocyte components to be equilibrated with lead added in vitro. At low lead concentrations, under 60 ,g/100 ml ES, the extent of ALA-D inhibition correlates with that of lead concentrations in the ALA-D fraction, and the decrease in ALA-D activity indicates the extent of lead saturation of ALA-D fraction proteins.
The saturation is attained at 80-110 gg'1O00 ml ES. Although an appreciable amount of lead is also found in the haemoglobin fraction that contains certain factors concerned in ALA-D inhibition, lead responsible for inducing the inhibition is not bound to haemoglobin fraction proteins but to ALA-D fraction proteins. Of three treatments or agents recovering the enzyme from lead effects, zinc is the only one that can fully restore the inhibition.
Blood lead concentrations are currently regarded as the most reliable index of exposure to lead. Over 90% of the blood lead is bound to the erythrocytes and seems to be in dynamic equilibrium with plasma lead.' 2 Plasma lead is more diffusible than erythrocyte lead and more important for evaluating the toxic effect of lead because the diffusible form exerts an influence on lead concentrations of other compartments and produces critical effect in the various organs.'-3 Erythrocytes rather behave as a repository for lead,4 which might produce some disturbances in erythrocyte metabolism such as Na, K-ATPase, ALA-D (S-aminolaevulinic acid dehydratase) activity. 56 Recently, Ong and Lee6 have reported that more than 85% of the 203Pb incorporated into erythrocytes in vitro is associated with the cytoplasmic components and the rest is bound to the stromal membrane. They suggested that the membranebound lead might affect the activity of Na, K-ATPase. Several workers7-9 have indicated that most of the labelled lead incorporated into erythrocytes in vitro is found in haemoglobin fractions. By contrast, Sakai et al'°reported that half the lead in erythrocyte haemolysate from a lead-exposed worker was found in protein fractions with a high Received 14 September 1981 Accepted 13 October 1981 molecular weight, including ALA-D. There is little information relating to lead-binding components in erythrocytes from a lead-exposed subject so far.
Erythrocyte ALA-D activity is the most sensitive indicator for blood lead concentrations, because the activity is specifically inhibited by lead at concentrations between 20 and 100 ,g/100 g blood."I 1-4 The highly purified enzyme from human erythrocytes is a homo-octamer with a molecular weight of 252 000 and is inhibited by lead at 1 and 5 ,uM'5; the crude enzyme is also inhibited at a concentration exceeding 1 ,u M. 16 These concentrations of lead in the reaction mixture are tenfold to fiftyfold higher than those in the mixture containing haemolysate from a lead-exposed worker. Sakai et al'0 suggested that certain factors detected in the haemoglobin fraction account for this discrepancy between in-vivo and in-vitro activity. As mentioned above, lead is found in the ALA-D fraction and also in the haemoglobin fraction that contains the factors. There Ten millilitres of heparinised venous blood were obtained from workers occupationally exposed to lead and from normal subjects with no history of exposure to lead.
All procedures for fractionating erythrocyte constituents were carried out at 4°C as previously described.'0 Packed erythrocytes from 10 ml of whole blood were washed three times in cooled saline (0-9% NaCI) and adjusted to the original haematocrit value with 25 mM phosphate buffer pH 7X0. Erythrocytes were completely lysed by sonicating. The lysate was centrifuged at 24 000 g for 30 minutes. The erythrocyte supematant (ES) was applied to a Sephadex G-200 column (2.6 x 90 cm) that had been equilibrated with 25 mM phosphate buffer pH 7-0 and eluted with the same buffer. Each fraction was collected in 11 ml (fig 1(a) , (b)) or 13 ml (fig 1(c) , (d)) aliquots; protein and lead concentrations and ALA-D activity were determined on each aliquot.
Protein concentrations were determined by the absorbance at 280 nm; ALA-D activity was determined by the method of Ushio et al77except that the assay mixture contained 0-5 ml of 0-2 M phosphate buffer pH 7-0, 0*5 ml of 20 mM ALA (8-aminolaevulinic acid) solution, 0-5 ml of 50 mM DTT (dithiothreitol), 0-1 ml of the fraction, and 0-9 ml of distilled water; lead concentrations were also determined by the method by Ushio et al,'7 using flame atomic absorption spectrophotometer.
LEAD-BINDING TO ERYTHROCYTE LYSATE
Normal erythrocyte lysate was prepared in the way described above, except that 40 mM Tris-HCI buffer pH 7-0 was used to adjust the volume back to the original haematocrit value. group.bmj.com on July 6, 2017 -Published by http://oem.bmj.com/ Downloaded from by the methods described above. ALA-D activity of the two types of ES sample was also determined with or without heating.'8 LEAD-BINDING TO WHOLE BLOOD Heparinised blood was obtained from normal donors with no history of exposure to lead. Four millilitres of blood were added to 1 ml of lead acetate solutions (0-7 ,g/ml of 0-9% NaCl) and incubated at 37°C for 60 minutes and then at 4°C for 20 hours. All procedures for the preparation of each fraction were carried out at 4°C. After centrifugation of lead-loaded blood, the packed erythrocytes were washed five times with cooled saline (0.9% NaCl); the original haematocrit value was restored with 40 mM Tris-HCI buffer pH 7*0. Erythrocytes were completely lysed by sonicating, and ES was obtained by centrifugation in the manner described above. Altogether 2-5 ml of ES was fractionated by passing through a Bio-gel A 1*5 m column (1.6 x 90 cm), which had been equilibrated with 40 mM Tris-HCl buffer pH 7*0 and eluted with the same buffer. Each fraction was collected in 4-7 ml aliquots on which ALA-D activity and protein concentrations were determined. After the addition of 1-5 N HC104 to each fraction (final 0* 15 N), the lead concentrations were directly determined using flameless atomic absorption spectrophotometer. Measurement of ALA-D activity of ES and its restoration by heat, zinc, or dithiothreitol were carried out by the method previously described.'8 (--) or 40 hours (--0--) as described in materials and methods. from the lead workers. In fig 1(a) Figure 3 shows the distribution of varying amounts of lead that are loaded to erythrocytes in vitro (table 2). As the amount of lead is increasingly totally restored to the control level by zinc, while neither dithiothreitol nor heat is sufficient to restore the inhibition, especially at high concentrations of lead.
Results

Discussion
This is the first report on the distribution of erythrocyte lead from lead workers in relation to ALA-D inhibition. We have shown that proteins in ALA-D Sakai, Yanagihara, Kunugi, and Ushio fraction have the highest affinity for lead among erythrocyte components in vivo and in vitro. The only investigation that has dealt with erythrocyte lead-binding proteins from lead-exposed workers is that by Raghavan et al,S who determined the lead content in four fractions of red blood cell haemolysate (haemoglobin lead, 10 000 molecular weight fraction lead, free lead, and residual lead). In their experiments, the haemoglobin fraction contained about half the erythrocyte lead. Several workers7-9 using radioactive lead have noted that haemoglobin has a high affinity for lead in vitro. Ong and prominent (fig 2) . This pattern of distribution of lead was similar to that found in ES from lead workers (fig 1) . It takes 20-40 hours'0 19 for the erythrocyte constituents to be equilibrated with lead added in vitro, as seen in blood from lead-exposed workers.
In a previous paper'0 we found that to induce or intensify the inhibition of ALA-D 5) are also compatible with those previously reported.'0 Zinc completely restored the inhibition of ALA-D activity to the control level at wide range of lead concentrations; dithiothreitol and heat did not completely restore activity, especially at high concentrations of lead. The blood used for the present study was fresh, and the enzyme was thought not to be oxidised because the activity was slightly increased by dithiothreitol at a lead concentration of 9,ug/ 100 ml ( fig 5) . In the previous experiment'0 the extent of restoration by dithiothreitol was larger than that of zinc, because the enzyme was partly oxidised during purification. Zinc does not bind to the enzvme unless the essential cysteinyl residues are reduced.20 Although zinc cannot restore the inactivation of ALA-D caused by oxidation, it is the only agent capable of fully restoring the inhibition due to lead.
Haemoglobin fraction proteins also have a high affinity for lead.9 We do not know whether or not all the lead in the haemoglobin fraction is bound to the haemoglobin molecules. The effect of lead on the haemoglobin fraction and on fractions other than ALA-D has not been clarified.
